Diffuse idiopathic skeletal hyperostosis associated ossification of the posterior longitudinal ligament

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang et al

The crossbow sign in extracranial giant cell arteritis

[Which taxonomy for inflammatory diseases in rheumatology? The concept of Psout]

Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro et al

[Multiple erythema annulare centrifugum associated with knee monoarthritis revealing Capnocytophagacanimorsus infection]

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes

Single tumor-like tophus

Gemcitabine-induced myopathy

Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler et al

Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and Huizinga

On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and Mammen

Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studies

Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al

Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

At the crossroads of gout and psoriatic arthritis: "psout"

Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara et al

Enthesitis of the ligamentum teres femoris in axial spondyloarthritis